Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2331049 Target Snapshot

Vascular endothelial growth factor receptor 2 · SINGLE PROTEIN · Danio rerio

41Compounds
33Assays
1Approved Drugs
34.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q5GIT4. Use UniProt Q5GIT4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q5GIT4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Vascular endothelial growth factor receptor 2 as ChEMBL target CHEMBL2331049, mapped to UniProt Q5GIT4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Vascular endothelial growth factor receptor 2
SINGLE PROTEIN · Danio rerio
As of 2026-09-14
ChEMBL target ID
CHEMBL2331049
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q5GIT4
Vascular endothelial growth factor receptor 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Vascular endothelial growth factor receptor 2 is the right protein anchor across sources, using UniProt Q5GIT4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelVascular endothelial growth factor receptor 2
UniProt AccessionQ5GIT4
Component TypeProtein
Sequence Length1357 aa

Vascular endothelial growth factor receptor 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Vascular endothelial growth factor receptor 2, mapped to UniProt Q5GIT4. Sequence length is 1357 aa.

Mapped IDQ5GIT4
Review nameVascular endothelial growth factor receptor 2
OrganismDanio rerio
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5034.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2331570 5.98 IC50 1050.0 Preclinical
CHEMBL2332849 5.92 IC50 1200.0 Preclinical
CHEMBL2332840 5.65 IC50 2250.0 Preclinical
CHEMBL1336 5.58 IC50 2600.0 Approved
CHEMBL2332870 5.29 IC50 5180.0 Preclinical
CHEMBL2332867 5.11 IC50 7730.0 Preclinical
CHEMBL2332871 5.07 IC50 8460.0 Preclinical
CHEMBL2332868 4.78 IC50 16600.0 Preclinical
CHEMBL2332869 4.75 IC50 17760.0 Preclinical
CHEMBL2332860 4.69 IC50 20230.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
4
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

33
Total Assays
16
Tested Compounds
1
Assay Types
Binding — 33 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 23 0
single protein format 8 16 4.8
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine